☆ 4.8 Article

Case Report: Blinatumomab therapy for the treatment of B-cell acute lymphoblastic leukemia patients with central nervous system infiltration

FRONTIERS IN IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Pharmacology & Pharmacy

Olverembatinib: First Approval

Sohita Dhillon

Summary: Olverembatinib is a third-generation oral BCR-ABL1 tyrosine kinase inhibitor developed for the treatment of various leukemias and solid tumors. It is unique in its ability to inhibit the resistant mutation T315I. The drug has received its first approval in China for TKI-resistant chronic-phase CML or accelerated-phase CML.

DRUGS (2022)

Add to Collection

Article Hematology

Efficacy and safety of CD19-specific CAR T-cell-based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

Yuekun Qi et al.

BLOOD (2022)

Add to Collection

Article Hematology

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Daniel A. Arber et al.

Summary: In 2016, the WHO, Society for Hematopathology, and European Association for Haematopathology collaborated to update the classification of myeloid neoplasms and acute leukemias, advancing the field of myeloid neoplasms and acute leukemias.

BLOOD (2022)

Add to Collection

Review Oncology

Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions

Maria Thastrup et al.

Summary: Effective delivery of anti-leukemic agents to the central nervous system (CNS) is crucial for curing childhood acute lymphoblastic leukemia. However, current therapy is associated with neurotoxicity and lacks sensitive biomarkers. Finding better treatment approaches, such as discovering biomarkers, developing new drugs, and improving immunotherapy, is necessary.

LEUKEMIA (2022)

Add to Collection

Article Oncology

Rapid and Deep Remission Induced by Blinatumomab for CD19-Positive Chronic Myeloid Leukemia in Lymphoid Blast Phase

Shyam A. Patel et al.

JCO PRECISION ONCOLOGY (2021)

Add to Collection

Review Oncology

Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data

Lennart Lenk et al.

CANCER AND METASTASIS REVIEWS (2020)

Add to Collection

Article Medicine, General & Internal

Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

Robin Foa et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Oncology

Successful application of anti-CD19 CAR-T therapy with IL-6 knocking down to patients with central nervous system B-cell acute lymphocytic leukemia

Li-Yun Chen et al.

TRANSLATIONAL ONCOLOGY (2020)

Add to Collection

Review Oncology

Recent advances in the treatment of acute lymphoblastic leukemia

Hind Rafei et al.

LEUKEMIA & LYMPHOMA (2019)

Add to Collection

Review Oncology

Managing CNS disease in adults with acute lymphoblastic leukemia

Richard A. Larson

LEUKEMIA & LYMPHOMA (2018)

Add to Collection

Article Medicine, General & Internal

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

Hagop Kantarjian et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection

Article Oncology

MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents

Kyogo Suzuki et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Add to Collection

Article Multidisciplinary Sciences

Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia

Zhaohui Gu et al.

NATURE COMMUNICATIONS (2016)

Add to Collection

Article Multidisciplinary Sciences

Structural and functional features of central nervous system lymphatic vessels

Antoine Louveau et al.

NATURE (2015)

Add to Collection

Editorial Material Orthopedics

National Institutes of Health Stroke Scale (NIHSS)

Li Khim Kwah et al.

JOURNAL OF PHYSIOTHERAPY (2014)

Add to Collection

Review Endocrinology & Metabolism

Drug transport across the blood-brain barrier

William M. Pardridge

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)

Add to Collection

Article Multidisciplinary Sciences

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

Ralf Bargou et al.

SCIENCE (2008)

Add to Collection

Article Hematology

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

Adele K. Fielding et al.

BLOOD (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.